Sepsis syndrome and bone marrow granulomatosis after intravesical bacillus Calmette-Guerin administration for bladder carcinoma;Syndrome septicemique et granulomatose medullaire dans les suites d'une instillation intra vesicale de BCG

Presse Medicale

Volumn 28, Issue 32, 1999, Pages 1753-1754

  Andres E ^a   Kuhnert, C ^a   Perrin, A E ^a   Averous, G ^a   Ruellan, A ^a   Goichot, B ^a   Schlienger, J L ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

AGED; ARTICLE; BLADDER CARCINOMA; BONE MARROW; CANCER IMMUNOTHERAPY; CASE REPORT; GRANULOMATOSIS; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; SEPSIS; BLADDER TUMOR; GRANULOMA; MYCOBACTERIUM BOVIS; PATHOLOGY;

ADMINISTRATION, INTRAVESICAL; AGED; BONE MARROW; GRANULOMA; HUMANS; MALE; MYCOBACTERIUM BOVIS; SEPSIS; URINARY BLADDER NEOPLASMS;

EID: 0033598511     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Alexandroff AB, Jackson AM, O'Donnell MA, James K. BCG immunotherapy of bladder cancer : 20 years on. Lancet 1999 ; 353:1689-94.
2. Lamm DL, van der Meijden PM, Morales A et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992 ; 147:596-600.
3. Izes JK, Bihrle W, Thomas CB. Corticosteroid-associated fatal mycobacterial sepsis occuring 3 years after instillation of intravesical bacillus Calmette-Guérin. J Urol 1993 ; 150:1498-1500.
4. Case records of the Massachusetts General Hospital. N Engl J Med 1998 ; 339:831-7.
5. Hellinger WC, Oldenburg WA, Alvarez S. Vascular and other serious infections with Mycobacterium bovis after intravesical administration for bladder cancer. South Med J 1995 ; 22:80-4.
6. Leebeek FWG, Ouwendijk RJT, Kolk AHJ et al. Granulomatous hepatitis caused by bacillus Calmette-Guérin (BCG) infection after BCG bladder instillation. Gut 1996 ; 18:616-18.
7. Graziano DA, Jacobs D, Lozano RG, Buck RL. A case of granulomatous hepatitis after intravesical bacillus Calmette-Guérin administration. J Urol 1991 ; 146:1118-19.
8. Paterson DL, Patel A. Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer : review of complications and their treament. Aust N Z Surg 1998 ; 68:340-4.
9. Van der Meijden PM. Practical approaches to the prevention and treatment of adverse reactions to BCG. Eur Urol 1995 ; 27(suppl 1) : 23-8.
10. DeHaven JI, Traynellis C, Riggs DR, Ting E, Lamm DL. Antibiotic and steroid therapy of massive systemic bacillus Calmette-Guérin toxicity. J Urol 1992 ; 147:738-42.